NASDAQ:NXL

Nexalin Technology Q3 2025 Earnings Results & Report

Nexalin Technology logo
$1.44 -0.06 (-4.00%)
Closing price 11/18/2026 03:58 PM Eastern
Extended Trading
$1.51 +0.07 (+4.86%)
As of 11/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nexalin Technology missed analyst expectations on both earnings and revenue in its Q3 2025 results, released November 14, 2025. The company reported EPS of -$3.90 versus the -$3.60 consensus estimate, while revenue of $18.15 thousand fell short of the $40 thousand estimate by $21.85 thousand.

Earnings Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call
7:00 AM ET

Nexalin Technology EPS Results

Actual EPS
-$3.90
Consensus EPS
-$3.60
Beat/Miss
Missed by -$0.30
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 7 quarters

Nexalin Technology Revenue Results

Actual Revenue
$18.15 thousand
Expected Revenue
$40 thousand
Beat/Miss
Missed by -$21.85 thousand
YoY Revenue Growth
N/A

Earnings Documents

Nexalin Technology Q3 2025 Earnings FAQ

Nexalin Technology (NASDAQ:NXL) reported earnings of -$3.90 per share for Q3 2025, missing the consensus estimate of -$3.60. The report was announced on Friday, November 14, 2025.

Nexalin Technology reported revenue of $18.15 thousand for Q3 2025, against a consensus estimate of $40 thousand.

Nexalin Technology Earnings Headlines

You missed yesterday's deadline…
In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.tc pixel
NXL - Nexalin Technology, Inc.
See More Nexalin Technology Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nexalin Technology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nexalin Technology and other key companies, straight to your email.

About Nexalin Technology

Nexalin Technology (NASDAQ:NXL) develops non-invasive neurostimulation devices for behavioral health applications. Its technology delivers low-level electrical signals through electrodes placed on the head, with the aim of supporting care for conditions such as anxiety, depression and insomnia.

The company’s product line includes its Gen-2 and Gen-3 cranial electrotherapy stimulation devices. Nexalin focuses on developing and commercializing these systems for use by healthcare providers and patients, and has pursued regulatory clearances and distribution opportunities in the United States and international markets.

View Nexalin Technology Profile